Risk of subsequent vitiligo in transplantation recipients with comorbid graft versus host disease: A nationwide population-based cohort study

Supplemental Figure 1. Flowchart of included patients
Supplemental Table 1. Characteristics of the study population
Supplemental Table 2. Subgroup analysis on the risk of vitiligo by HSCT graft type, stem cell source, and comorbid GVHD
Supplemental Table 3. Risks and incidence rates of vitiligo in patients with transplantation according to a health check-up database.